June 17, 2022 News by Mary Chapman Innovative Trials, MS Society UK Collaborate on MS Research Innovative Trials has selected the MS Society UK as its charity partner for the next year, and intends to raise at least Ā£3,000 (about $3,600) to support multiple sclerosis (MS) research and the society’s quest for a world without MS. Innovative Trials works with pharmaceutical companies and…
February 16, 2022 News by Lindsey Shapiro, PhD UK MS Society Investing $1.5M in Support of 9 Research Projects The MS SocietyĀ of the U.K. intends to raise over Ā£1.1 million (about $1.5 million) to support nineĀ multiple sclerosis (MS) research projects, marking the return of the grants program it put on hold due to the COVID-19 pandemic. Funding will support research in the…
February 16, 2022 News by Steve Bryson, PhD Newly Created Cells Better at Repairing Myelin in Preclinical Study Therapeutics designed to produce new oligodendrocytes ā the cells responsible for the protective myelin sheath that is damaged in multiple sclerosis (MS) ā might be the most effective approach for disorders such as MS, according to a study conducted in a fish model. That’s because oligodendrocytes that survive being…
December 22, 2021 News by Marta Figueiredo, PhD 3 New COVID-19 Treatments Now Available to MS Patients in UK People with multiple sclerosis (MS) living in the U.K. are now eligible to receive one of three new treatments for COVID-19 that are meant to prevent serious disease in at-risk populations who tested positive for the virus. First available under this plan were Regeneron and Rocheās antibody-based therapy…
November 10, 2021 Columns by Beth Ullah MS Advocacy Gives Me Strength and Purpose I want to help in any way I possibly can. My lonely confusion in the early days after being diagnosed with aggressive relapsing-remitting multiple sclerosis was mentally and physically paralyzing. However, this column isnāt about how āHurricane MSā battered my body. Instead, it’s about why I chose to…
October 11, 2021 News by Patricia Inacio, PhD NICE Opposes Ponvory Being Added to NHS for England and Wales The National Institute for Health and Care Excellence (NICE) will not recommend that Ponvory (ponesimod) be added to the National Health Service (NHS) of England and Wales for people with active, relapsing forms of multiple sclerosis (MS). The provisional decision, made because Ponvory was not found to be…
October 6, 2021 News by Mary Chapman MS Society Marks UK’s Black History Month With ‘Proud to Be’ Stories The MS Society in the U.K. is again marking Black History Month, observed each October in the United Kingdom, to celebrate and call attention to the needs of Black people in the multiple sclerosis (MS)Ā community. To that end, the nonprofit organization is highlighting the stories and challenges…
August 20, 2021 News by Margarida Maia, PhD Barriers Limit Sativex Access for Patients With Spasticity in UK Sativex (nabiximols), a cannabis-based oral spray approved in the U.K. to ease spasticity ā or muscle stiffness and spasms ā in adults with multiple sclerosis (MS), remains unavailable to many patients there, according to a report by the MS Society UK. Sativex is the only licensed…
August 10, 2021 News by Marta Figueiredo, PhD Trial Will Test Mavenclad for Advanced Progressive MS After some delays due to the COVID-19 pandemic, the Phase 2/3 clinical trial evaluating whether Mavenclad (cladribine) can slow hand and arm function worsening in adults with progressive multiple sclerosis (MS) and very limited walking abilities, has recruited its first patient. The study,Ā ChariotMS (NCT04695080), aims to…
April 30, 2021 Columns by John Connor You’ve Got to Hide Your MS Away In honor of MS Awareness Week, observed in the U.K. April 19ā25, the MS Society released results of a survey about the barriers that keep multiple sclerosis patients from sharing their health status. Multiple Sclerosis News Today‘s Mary Chapman reportedĀ that a whacking one-third have stayed silent about their diagnosis.
February 11, 2019 News by Jonathan Grinstein Petition Urges NHS England to Make Ocrevus Available for PPMS Patients More than 21,000 people have signed a petition calling for Ocrevus (ocrelizumab) to be made available by the National Health Service (NHS) in England for people with primary progressive multiple sclerosis (PPMS). According to anĀ MS Trust press release, the…
November 9, 2018 Columns by John Connor Medical Marijuana in the UK: So Near and Yet So Far As I’m writing this, my right arm is tight and my right hand is cramped up. I was out working last night and night work always shatters me the next morning when I awaken with exacerbated MS symptoms. Luckily, I never learned to be a copy typist when I…